Indian Pharmacopoeia Commission Participation in International Meeting
A delegation from the Indian Pharmacopoeia Commission (IPC), Ministry of Health & Family Welfare, Government of India, participated in the 16th International Meeting of World Pharmacopoeias (IMWP) and the accompanying Stakeholders' Meeting held in Brasília, Brazil, from June 15th to 17th, 2026. The delegation was led by Dr. V. Kalaiselvan, Secretary-cum-Scientific Director, along with Dr. Pawan Saini and Dr. Shruti Rastogi.
The meeting was coordinated by the World Health Organization (WHO) and brought together representatives from leading pharmacopoeias worldwide, including the Brazilian Pharmacopoeia, European Pharmacopoeia, Japanese Pharmacopoeia, Korean Pharmacopoeia, Mexican Pharmacopoeia, Russian Pharmacopoeia, British Pharmacopoeia, United States Pharmacopeia, State Pharmacopoeia of the Republic of Uzbekistan, Vietnamese Pharmacopoeia, and The International Pharmacopoeia of WHO.
During the meeting, Dr. Kalaiselvan presented key updates on the Indian Pharmacopoeia, highlighting recent advancements in pharmacopoeial standards, modernization initiatives, and India's contributions towards global harmonization of medicine quality standards. Discussions reaffirmed that the standards of the Indian Pharmacopoeia are comparable with leading international pharmacopoeias. India was specifically recognized for its leadership in developing and establishing quality standards for anti-tuberculosis medicines, anti-cancer therapeutics, blood and blood products, medicines used in the management of anaemia, and other complex pharmaceutical molecules.
The Indian delegation actively contributed to discussions on modern microbiological methods, pharmacopoeial convergence, and environmental sustainability in pharmaceutical standards. At the Stakeholders' Meeting, Dr. Kalaiselvan showcased IPC's role in strengthening public health through science-based standards and regulatory support, while emphasizing the importance of international cooperation in ensuring the quality, safety, and efficacy of medicines worldwide. India's participation further strengthened collaboration with international pharmacopoeias and reaffirmed the country's growing leadership in shaping global pharmaceutical quality standards.